Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

10X Genomics Inc

TXG
Current price
8.17 USD -0.07 USD (-0.85%)
Last closed 8.54 USD
ISIN US88025U1097
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 1 051 564 352 USD
Yield for 12 month -64.01 %
1Y
3Y
5Y
10Y
15Y
TXG
21.11.2021 - 28.11.2021

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. Address: 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.46 USD

P/E ratio

Dividend Yield

Current Year

+610 785 000 USD

Last Year

+618 727 000 USD

Current Quarter

+154 883 000 USD

Last Quarter

+165 021 000 USD

Current Year

+414 482 000 USD

Last Year

+409 313 000 USD

Current Quarter

+105 445 000 USD

Last Quarter

+110 955 000 USD

Key Figures TXG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -146 882 000 USD
Operating Margin TTM -31.33 %
Price to Earnings
Return On Assets TTM -12.43 %
PEG Ratio
Return On Equity TTM -22.03 %
Wall Street Target Price 12.46 USD
Revenue TTM 624 662 016 USD
Book Value 5.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 9.80 %
Dividend Yield
Gross Profit TTM 427 012 992 USD
Earnings per share -1.30 USD
Diluted Eps TTM -1.30 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -25.14 %

Dividend Analytics TXG

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History TXG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:2
Payout Ratio TTM
Last Split Date 17.07.2006

Stock Valuation TXG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 196.08
Enterprise Value Revenue 1.13
Price Sales TTM 1.68
Enterprise Value EBITDA -40.69
Price Book MRQ 1.49

Financials TXG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TXG

For 52 weeks

6.78 USD 24.76 USD
50 Day MA 8.78 USD
Shares Short Prior Month 12 860 779
200 Day MA 14.66 USD
Short Ratio 4.01
Shares Short 15 497 650
Short Percent 21.36 %